PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | 0.0% | 19 | +46.2% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 13 | +44.4% | 0.00% | – |
Q1 2022 | $1,000 | – | 9 | +800.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
Q1 2020 | $135,000 | -70.9% | 3,998 | -61.0% | 0.01% | -64.3% |
Q4 2019 | $464,000 | +2477.8% | 10,247 | +1945.3% | 0.03% | +2700.0% |
Q3 2019 | $18,000 | -93.3% | 501 | -91.9% | 0.00% | -94.7% |
Q2 2019 | $268,000 | +13.1% | 6,159 | -1.0% | 0.02% | 0.0% |
Q1 2019 | $237,000 | +19.7% | 6,223 | +35.2% | 0.02% | +5.6% |
Q4 2018 | $198,000 | +3200.0% | 4,603 | +3735.8% | 0.02% | – |
Q3 2018 | $6,000 | -99.8% | 120 | +22.4% | 0.00% | – |
Q2 2018 | $3,141,000 | +104600.0% | 98 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | 0.0% | 98 | +66.1% | 0.00% | – |
Q2 2017 | $3,000 | -76.9% | 59 | -79.8% | 0.00% | -100.0% |
Q1 2017 | $13,000 | -31.6% | 292 | -50.5% | 0.00% | -50.0% |
Q4 2016 | $19,000 | -9.5% | 590 | +18.0% | 0.00% | 0.0% |
Q3 2015 | $21,000 | -40.0% | 500 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $35,000 | -20.5% | 500 | 0.0% | 0.00% | -20.0% |
Q1 2015 | $44,000 | 0.0% | 500 | 0.0% | 0.01% | -16.7% |
Q4 2014 | $44,000 | -8.3% | 500 | 0.0% | 0.01% | -14.3% |
Q3 2014 | $48,000 | -25.0% | 500 | -28.6% | 0.01% | -22.2% |
Q2 2014 | $64,000 | +30.6% | 700 | 0.0% | 0.01% | +12.5% |
Q1 2014 | $49,000 | +22.5% | 700 | 0.0% | 0.01% | +14.3% |
Q4 2013 | $40,000 | +17.6% | 700 | 0.0% | 0.01% | +16.7% |
Q3 2013 | $34,000 | +70.0% | 700 | 0.0% | 0.01% | +50.0% |
Q2 2013 | $20,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |